You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cancer micrometastases
|
|---|---|
| Published in |
Nature Reviews Clinical Oncology, April 2009
|
| DOI | 10.1038/nrclinonc.2009.44 |
| Pubmed ID | |
| Authors |
Klaus Pantel, Catherine Alix-Panabières, Sabine Riethdorf |
| Abstract |
Early spread of tumor cells is usually undetected by current imaging technologies. In patients with cancer and no signs of overt metastases sensitive methods have been developed to detect circulating tumor cells (CTCs) in the peripheral blood and disseminated tumor cells (DTCs) in the bone marrow. These technologies can be classified into cytometric and/or immunological and molecular approaches. Interestingly, the bone marrow seems to be a common homing tissue for cells derived from various epithelial tumors, and level 1a data from European and US groups have confirmed the prognostic impact of DTCs in the bone marrow of patients with breast cancer. Sequential peripheral blood analyses, however, are more convenient than bone marrow analyses for patients with solid tumors, and many research groups are currently assessing the clinical use of CTCs for assessment of prognosis and monitoring of systemic therapy. Molecular characterization of DTCs and CTCs opens a new avenue for understanding cancer dormancy, and might contribute to the identification of metastatic stem cells with important implications for future therapies. This Review focuses on the clinical relevance of the latest research results on blood-borne cancer micrometastases in patients with cancer. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 449 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 3 | <1% |
| United States | 3 | <1% |
| Spain | 2 | <1% |
| Netherlands | 1 | <1% |
| Sweden | 1 | <1% |
| United Kingdom | 1 | <1% |
| Belgium | 1 | <1% |
| Indonesia | 1 | <1% |
| Russia | 1 | <1% |
| Other | 3 | <1% |
| Unknown | 432 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 90 | 20% |
| Researcher | 86 | 19% |
| Student > Master | 49 | 11% |
| Student > Bachelor | 41 | 9% |
| Other | 26 | 6% |
| Other | 75 | 17% |
| Unknown | 82 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 109 | 24% |
| Medicine and Dentistry | 91 | 20% |
| Biochemistry, Genetics and Molecular Biology | 66 | 15% |
| Engineering | 27 | 6% |
| Chemistry | 14 | 3% |
| Other | 45 | 10% |
| Unknown | 97 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 November 2023.
All research outputs
#2,481,972
of 23,575,346 outputs
Outputs from Nature Reviews Clinical Oncology
#586
of 2,095 outputs
Outputs of similar age
#7,995
of 94,292 outputs
Outputs of similar age from Nature Reviews Clinical Oncology
#2
of 15 outputs
Altmetric has tracked 23,575,346 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,095 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.6. This one has gotten more attention than average, scoring higher than 71% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 94,292 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.